Topic
Pharmaceuticals
1,010 published works
Drug & Device Law
Running the Table – The Ten Best Prescription Drug/Medical Device Decisions of 2025
By Bexis
A year ago, Bexis thought this would be the last blogpost he would ever write, and that he would retire along with 2025. Not gonna happen – at least not…
Substance Law Blog
Drug Identification Numbers (DINs) in Canada
By Publisher
What is a Drug Identification Number (DIN)? The Purpose of a DIN A Drug Identification Number, or DIN, is a unique eight-digit code assigned by Health Canada to drug products…
GoodLifeSci
EU Pharma Package: Sharp New Tools With Limited Protections
By Maarten Meulenbelt, Josefine Sommer, Anne Robert, Dr. Chris Boyle, Alix Vermulst
Last week, concluding a seven-year process, the Council of the European Union and the European Parliament agreed on the EU Pharma Package consisting of a new Pharmaceutical Directive and Pharmaceutical…
Pro Te: Solutio
Memento Michigan Compiled Law § 600.2946(5): An Homage to Michigan’s Former Drug Immunity Law
By Butler Snow
In 1995, the Michigan Legislature enacted its Drug Immunity Law, which provided an absolute defense for pharmaceutical companies in product liability suits stemming from the safety and efficacy of their…
As Prescribed
Agreement Reached on EU Pharma Package, but Questions Remain
By Morgan Lewis
Two and a half years after the initial proposal, agreement has been reached by the EU institutions on the so-called EU Pharma Package. The Package represents a comprehensive overhaul of…
Inside EU Life Sciences
EU Announces Political Agreement on Pharma Law Review
By Grant Castle, Peter Bogaert, Robin Blaney, Marie Doyle-Rossi, Spiros Drosos, Anna Wawrzyniak
At just after 5 am on 11 December 2025, the EU Parliament and the Council reached agreement on a new directive and a new regulation that will result in a…
BioSlice Blog
European institutions agree on the reform to the EU Regulatory Framework for Medicinal Products
By Alexander Roussanov, Libby Amos-Stone, Christopher Bates, Ana Gonzalez-Lamuno
On 11 December, after overnight interinstitutional negotiations between the European Parliament and the Council of the European Union (“Council”) and the European Commission, the institutions reached a provisional political agreement…
Big Molecule Watch
FDA Approves Lupin’s Pegfilgrastim Biosimilar, ARMLUPEG
Lupin Limited announced on December 1 that it received FDA approval for its biosimilar product, ARMLUPEG (pegfilgrastim-unne). ARMLUPEG is approved as a 6 mg/0.6 mL single-dose prefilled syringe presentation, referencing…
Global Policy Watch
Landmark UK-US Pharmaceutical Deal
By Grant Castle, Raj Gathani, Dan Spivey
On 1 December 2025, the UK Government announced a “landmark” UK-US pharmaceutical deal. Under the deal, the UK claims to be (so far) the only country to secure zero-percent tariffs…
Pharmacy & Healthcare Legal Blog
Navigating 2026 Part D pharmacy reimbursements. Resources.
Starting January 1, 2026, pharmacies will be reimbursed under a different model for dispensing certain Part D Medicare drugs. These changes are a part of the implementation of the Inflation…